Patents Assigned to Jiangsu Mircromedmark Biotech Co., LTD.
  • SiRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia
    Patent number: 10273481
    Abstract: Provided is an siRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia, and particularly, provided are a method of a tandem expression for siRNA of BTK, and an siRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: April 30, 2019
    Assignee: Jiangsu Mircromedmark Biotech Co., LTD.
    Inventors: Chenyu Zhang, Ke Zeng, Hongwei Gu, Xueliang Wang